Jean-Manasse Theagene
Director · MAIA Biotechnology, Inc.
- 2024
- Oct 2, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jean-Manasse Theagene files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Vlad Vitoc - $302K in MAIA purchases and sales in the last 12 months
- Stan Smith - $298K in MAIA purchases and sales in the last 12 months
- Ramiro Guerrero - $252K in MAIA purchases and sales in the last 12 months
- Ngar Yee Louie - $211K in MAIA purchases and sales in the last 12 months
- Steven M. Chaouki - $106K in MAIA purchases and sales in the last 12 months
- Cristian Luput - $52K in MAIA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jean-Manasse Theagene?
Jean-Manasse Theagene is a corporate insider, tracked as Director of MAIA Biotechnology, Inc. (MAIA). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jean-Manasse Theagene submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.